Send feedback

EVC2 p.Arg608His

c.1823G>A · rs145693546 · VCV281122

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 12 submitters
AlphaMissense
likely benign
0.0902 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.19%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
acrofacial dysostosis, Weyers type

Computational evidence

Protein change
AlphaMissense0.0902likely benign
REVEL0.182moderately benign-leaning
SaProtLLR -7.73tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 2GERP 0.69, phastCons 0.96
Regional constrainto/e 1.14unconstrained · MANE · 146 kb · p 1.9e-08 · regional, not allelic
Overall
CADD19.37PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.19% European (non-Finnish) · 2,237/1,179,980 alleles
Filtering AF 0.183% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.18%
Overall 0.174% 2,808/1,613,972 alleles · rare exomes 2,618/1,461,868 · genomes 190/152,104 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 1.27% 79
European (non-Finnish)grpmax 0.19% 527
Remaining individualsnot grpmax-eligible 0.15% 665
Admixed American 0.0867% 1,154
Finnishnot grpmax-eligible 0.0359% 2,783
African / African-American 0.0187% 5,355
Middle Eastern 0.0165% 6,058
South Asian 0.0121% 8,280
East Asian 0.00223% 44,862

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EVC2
Protein
p.Arg608His
Coding
c.1823G>A
MANE Select
NM_147127
dbSNP
rs145693546
Type
single nucleotide variant
Location
chr4:5628622 (GRCh38)
Gene constraint
LOEUF 1.092 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 73.33
Full EVC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/evc2-p-arg608his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown